Search

everythinglearnresearchcommunity

for

Search:↓

There are many treatments for common hair loss, but more trials are needed to decide which are best.

Baricitinib is a new, effective treatment for advanced alopecia areata but is costly and has risks.

The document says homoeopathic treatments are good for hair regrowth in alopecia areata but doesn't give proof.

A young child with complete hair loss improved significantly with a combination of hair growth treatments and laser therapy.

Most children with alopecia areata improved with treatment, but those with more hair loss had worse outcomes.

People with Down syndrome have a higher risk of skin disorders and need better screening and treatment.

A woman with systemic sclerosis developed a unique scarring hair loss combining features of systemic sclerosis and frontal fibrosing alopecia.

Getting insurance to cover the hair loss treatment tofacitinib is hard because it's not officially approved for that use.

The document concludes that atopic dermatitis in dogs is managed with various treatments including antipruritics, supplements, and possibly immunotherapy.

Different staff in a dermatology clinic understand mostly their own tasks, not the full clinic process.

Severe Hidradenitis Suppurativa increases missed and unproductive workdays.

Smoking and certain health conditions like thyroid disease may make palmoplantar pustulosis harder to treat.

The document concludes that diagnosing female hair loss requires careful examination, with treatments varying by condition and psychological support often necessary.

Most patients with rheumatoid arthritis continued methotrexate treatment over two years, but those who stopped and restarted experienced more side effects and less improvement.

Different hair disorders have specific treatments and outcomes, with some resolving on their own and others requiring medication or emotional support.

The most common cause of hair loss in children is tinea capitis, followed by alopecia areata and telogen effluvium.

Different scalp and hair disorders are more common in certain ethnic groups, with the most common being androgenetic alopecia, which is treated with medications like minoxidil and finasteride.

OCT can effectively screen and diagnose various medical conditions non-invasively.

All four treatments for early rheumatoid arthritis had similar safety profiles.

Alopecia Areata is an unpredictable autoimmune hair loss condition with limited and variable treatment effectiveness.

Methotrexate dose has little effect on its toxicity when used with adalimumab for early rheumatoid arthritis.

Dutasteride 0.5mg improves hair growth in 78% of people with hair loss, but may cause sexual problems in some.

Finasteride treatment lowers urine androgen and prostaglandin levels, making them potential markers for effectiveness.

Baricitinib 4 mg is effective and safe for treating severe alopecia areata.

Tofacitinib can cause unusual hair growth, requiring careful monitoring and possible laser hair removal.

Switching between the medications tofacitinib and baricitinib can be effective for treating hair loss in alopecia areata.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Baricitinib helped most teenagers with severe hair loss regrow hair and had mild side effects.

COVID-19 vaccines may rarely worsen hair loss in people with severe alopecia, but the benefits of vaccination still outweigh this risk.